Barnidipine: a new calcium channel blocker for hypertension treatment

References

• Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Heart, Lung and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 42, 1206–1252 (2003).
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension–European Society of Cardiology. 2003 guidelines for the management of arterial hypertension. J. Hypertens. 21, 1011–1053 (2003).
   PubMed Web of Science ®Google Scholar
• Abe K, on behalf of the J-MUBA Study Group. Overview of the Japanese multicenter study on barnidipine with ambulatory blood pressure monitoring. Blood Press. Monit. 6(Suppl. 2), S3–S7 (2001).
   Google Scholar
• Yoshinaga K, Iimura O, Abe K et al. Antihypertensive effect and safety of YM730 (mepirodipine hydrochloride) in patients with severe hypertension. Shinryo To Shinyaku 27, 1657–1670 (1990).
   Google Scholar
• Yoshinaga K, Iimura O, Abe K et al. Clinical usefulness of barnidipine hydrochloride (YM730), a calcium antagonist, in the treatment of renovascular hypertension (continued report) – aggregate results incorporating additional study. Ther. Res. 15, 3267–3275 (1994).
   Google Scholar
• Buranakitjaroen P, Koanantakul B, Phoojaroenchanachai M, Chawantanpipat C. The efficacy and tolerability of barnidipine hydrochloride in Thai patients with hypertension. J. Intl Med. Res. 32, 185–200 (2004).
   PubMed Web of Science ®Google Scholar
• Hypoca®, product information. Yamanouchi Pharmaceutical Co. Ltd, Tokyo, Japan.
   Google Scholar
• Teramura T, Watanabe T, Higuchi S, Hashimoto K. Metabolism and pharmacokinetics of barnidipine hydrochloride, a calcium channel blocker, in man following oral administration of its sustained release formulation. Xenobiotica 27, 203–216 (1997).
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Motomura S, Tsujimoto G, Higuchi S, Teramura T. Phase I study of a calcium antagonist, YM730 (mepirodipine hydrochloride). Clin. Rep. 24, 4443–4458 (1990).
   Google Scholar
• Park HC, Kwon KH, Noh HJ et al. Open-label, uncontrolled clinical trial of barnidipine hydrochloride in Korean patients with renal parenchymal hypertension. Curr. Ther. Res. Clin. Exp. 61, 927–937 (2000).
   Web of Science ®Google Scholar
• Beudeker HJ, van der Velden J-W, van der Aar EM. Interaction profile and tolerability of barnidipine. Int. J. Clin. Pract. 114(Suppl.), 36–40 (2000).
   Google Scholar
• Korstanje C. Barnidipine, a long-acting slow onset calcium antagonist. Int. J. Clin. Pract. 114(Suppl.), 2–5 (2000).
   Google Scholar
• Smilde JG. The long-term efficacy and safety profile of barnidipine. Int. J. Clin. Pract. 114(Suppl.), 20–25 (2000).
   Google Scholar
• Naber FB, Hage R, Mortelmans J. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study. Int. J. Clin. Pract. 114(Suppl.), 2735 (2000).
   Google Scholar
• Hart W, Holwerda NJ. Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Cardiovasc Drug. Ther. 11, 637–643 (1997).
   PubMed Web of Science ®Google Scholar
• Otterstad JE, Ruilope LM. Treatment of hypertension in the very old. Int. J. Clin. Pract. 114(Suppl.), 10–19 (2000).
   Google Scholar
• Noda H, Fujita T, Ogata E. The role of renal hemodynamics in the antihypertensive action of mepirodipine, a new calcium antagonist. Jpn Circ. J. 56, 21–26 (1992).
   PubMedGoogle Scholar
• Huh WS, Kim YS, Han JS et al. Antihypertensive efficacy and tolerability of barnidipine hydrochloride in patients with renal parenchymal hypertension. Curr. Ther. Res. Clin. Exp. 61, 395–405 (2000).
   Web of Science ®Google Scholar
• Yoshinaga K, Iimura O, Abe K et al. Clinical evaluation of YM730 (mepirodipine hydrochloride) in the treatment of essential hypertension: double-blind comparative study with sustained release preparation of nicardipine hydrochloride as control. Igaku No Ayumi 156, 543–560 (1991).
   Google Scholar
• Yoshinaga K, Iimura I, Abe K et al. Investigation of clinical usefulness of mepirodipine hydrochloride (YM730), a calcium antagonist, in patients with renovascular hypertension. Jin To Toseki 30, 121–126 (1991).
   Google Scholar
• Yoshinaga K, Iimura I, Abe K et al. Investigation of clinical usefulness of mepirodipine hydrochloride (YM730), a calcium antagonist, in patients with renal parenchymal hypertension. Jin To Toseki 26, 1045–1058 (1990).
   Google Scholar
• Liau CS, Chien KL, Chao CL, Lee TM. Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients. J. Intl Med. Res. 30, 330–336 (2002).
   PubMed Web of Science ®Google Scholar
• van der Velden JW, Beudeker HJ, Nishi M. Diversity and intensity of adverse events in the treatment of hypertension with barnidipine. Blood Press. 7(Suppl. 1), S27–S29 (1998).
   Google Scholar
• Malhotra HS, Plosker GL. Barnidipine. Drugs 61, 989–996 (2001).
   PubMed Web of Science ®Google Scholar
• Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press. 7(Suppl. 1), S22–S26 (1998).
   Google Scholar
• Matsuura H, Imai Y, Shimada K, Kuwajima I, Abe K, on behalf of the J-MUBA Study Group. Effects of the long-acting calcium channel blocker barnidipine hydrochloride on 24-h ambulatory blood pressure: results of the Japanese Multicenter Study on Barnidipine with Ambulatory Blood Pressure Monitoring. Blood Press. Monit. 6(Suppl. 2), S41–S47 (2001).
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Society of Hypertension Writing Group. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 21, 1983–1992 (2003).
   PubMed Web of Science ®Google Scholar
• Williams B, Poulter NR, Brown MJ et al. British Hypertension Society guidelines. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 – BHS IV. J. Human Hypertens. 18, 139–185 (2004).
   PubMed Web of Science ®Google Scholar